BIOSTAR teases next-generation AMD motherboards for Computex, possibly X970e
BIOSTAR says it will bring “next-generation AMD” motherboards to COMPUTEX Taipei 2026, alongside Intel 800 series boards, VALKYRIE gaming models, AI PC platforms, Radeon RX graphics cards, DDR5 and DDR4 memory, and PCIe M.2 and SATA SSDs.
AMD has already moved its AM5 platform to the X870E/X870 generation. If BIOSTAR is referring to a new AMD chipset rather than another X870 refresh, this should point to X970 or a related 900-series platform for next-generation Ryzen processors. Intel is already confirmed to be using Z990 and Z970 names, so is AMD also sticking to 900-series naming? That’s a great question we don’t have an answer for yet.
On the consumer and gaming side, BIOSTAR will present its next-generation AMD and Intel 800 series motherboards, the flagship VALKYRIE gaming series, and mainstream AI PC platforms, complemented by graphics cards based on the AMD Radeon RX series. The showcase also reflects strong demand in one of the year’s most active memory segments, with a full lineup spanning both DDR5 and DDR4, along with PCIe M.2 and SATA SSDs-a dual-track approach that mirrors continued demand across both current-generation and established platforms.
— Biostar PR
AMD has not announced such chipsets yet. The company has only confirmed long-term AM5 support, while Zen 6-based Ryzen desktop processors are expected by late 2026 at the earliest, or possibly later depending on AMD’s final client roadmap.
As we have already said, AMD has a history of offering early teasers of next-gen client platforms at Computex. New motherboards, X3D showcase, architecture IPC of gaming uplift claims or sometimes demos with next-gen GPUs. At the very least, Biostar PR strongly suggests that we will see Zen6 showcase and next-gen boards on the Computex show floor.
BIOSTAR’s release does not mention Zen 6, Ryzen 10000, X970, or B950 by name. For now, the company is only confirming next-generation AMD boards for its Computex booth. For this reason, we asked Biostar for clarification. Should we hear something useful, we will update this post.
Source: Biostar PR
